Friedland, Gerald, Saye Khoo, Christopher Jack, and Umesh Lalloo. "Administration of efavirenz (600 mg/day) with rifampicin results in highly variable levels but excellent clinical outcomes in patients treated for tuberculosis and HIV." The Journal of antimicrobial chemotherapy 58, no. 6 (2006): 1299-302.